Skip to main content
SpringerLink
Log in

Possible physiological significance of the initial step in the catabolism of noradrenaline in the central nervous system of the rat

  • Published:
Naunyn-Schmiedeberg's Archives of Pharmacology Aims and scope Submit manuscript

Summary

The hypothalamus, the cerebral cortex and the cerebellar cortex of the rat were labelled in vitro with 3H-noradrenaline (3H-NA) and the metabolism of the tritiated transmitter was studied during spontaneous outflow and under conditions of release elicited by exposure to 20 mM K+.

In the three areas of the central nervous system of the rat, 3H-NA accounted for approximately 40% of the total radioactivity in spontaneous outflow while the 3H-O-methylated deaminated fraction (3H-OMDA) and 3H-3,4-dihydroxyphenylglycol (3H-DOPEG) were the main metabolites. Exposure to the reserpine-like agent, Ro 4-1284 induced a selective increase in the spontaneous outflow of 3H-DOPEG, while the contribution of the 3H-OMDA metabolites to the release induced by Ro 4-1284 was very small.

During 3H-transmitter release elicited by exposure to 20 mM K+, approximately 80% of the radioactivity was collected as unmetabolized 3H-NA, while 3H-DOPEG was the main metabolite formed under these experimental conditions. Exposure to cocaine prevented 3H-DOPEG formation from 3H-NA released by K+, indicating that 3H-DOPEG was formed after neuronal reuptake of the transmitter released by K+.

After in vitro labelling with 3H-NA, the unmetabolized transmitter represented approximately 70% of the total radioactivity retained in the tissue. However, when 3H-NA was administered in vivo, by intraventricular injection, only 30% of the total radioactivity retained by the tissue was accounted for by 3H-NA, and 60% of the radioactivity corresponded to the 3H-OMDA fraction, most of which was retained as 3H-MOPEG sulfate.

When the rats were pretreated with pyrogallol, free 3H-DOPEG accounted for nearly 50% of the radioactivity retained in the three areas of the central nervous system after in vivo labelling with 3H-NA. When monoamine oxidase was inhibited by pargyline and 3H-NA was administered by intraventricular injection, 3H-NMN accounted for approximately 50% of the total radioactivity retained in the three areas of the central nervous system of the rat.

The results obtained are compatible with the view that formation of the deamined glycol is the first step in the metabolism of 3H-NA in the rat central nervous system. In addition, it is concluded that the determination of the levels of some NA metabolites retained in the central nervous system does not necessarily represent an accurate reflection of the degree of central noradrenergic activity or of selective metabolic pathways. Consequently, in studies on the metabolism of NA it is important to take into account not only the transmitter and its metabolites in the tissue but also in the outflow from the structures studied either under in vivo or in vitro conditions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Adler-Graschinsky, E., Langer, S. Z., Rubio, M. C.: Metabolism of norepinephrine released by phenoxybenzamine in isolated guinea-pig atria. J. Pharmacol. exp. Ther. 180, 286–301 (1972)

    Google Scholar 

  • Azzaro, A. J., Rutledge, C. O.: Selectivity of release of norepinephrine, dopamine and 5-hydroxytryptamine by amphetamine in various regions of rat brain. Biochem. Pharmacol. 22, 2801–2813 (1973)

    Google Scholar 

  • Baldessarini, R. J., Kopin, I. J.: The effect of drugs on the release of norepinephrine-3H from central nervous system tissues by electrical stimulation in vitro. J. Pharmacol. exp. Ther. 156, 31–38 (1967)

    Google Scholar 

  • Braestrup, C., Nielsen, M.: Intra- and extraneuronal formation of the two major noradrenaline metabolites in the ens of rats. J. Pharm. Pharmacol. 27, 413–419 (1975)

    Google Scholar 

  • Ceasar, P. M., Hague, P., Sharman, D. F., Werdinius, B.: Studies on the metabolism of catecholamines in the central nervous system of the mouse. Brit. J. Pharmacol. 51, 187–195 (1974)

    Google Scholar 

  • Coyle, J. T., Snyder, S. H.: Catecholamine uptake by synaptosomes in homogenates of rat brain: Stereospecificity in different areas: J. Pharmacol. exp. Ther. 170, 221–231 (1969)

    Google Scholar 

  • Cubeddu, L. X., Barnes, E. M., Langer, S. Z., Weiner, N.: Release of norepinephrine and dopamine-beta-hydroxylase by nerve stimulation. I. Role of neuronal and extraneuronal uptake and of alpha-presynaptic receptors. J. Pharmacol. exp. Ther. 190, 431–450 (1974a)

    Google Scholar 

  • Cubeddu, L. X., Langer, S. Z., Weiner, N.: Relationship between alpha-receptor block, inhibition of neuronal uptake and release and metabolism of 3H-norepinephrine in the cat spleen. J. Pharmacol. exp. Ther. 188, 368–385 (1974b)

    Google Scholar 

  • Dubocovich, M. L., Langer, S. Z.: Effects of flow-stop on the metabolism of 3H-noradrenaline released by nerve stimulation in the perfused cat's spleen. Naunyn-Schmiedeberg's Arch. Pharmacol. 278, 179–194 (1973)

    Google Scholar 

  • Dubocovich, M. L., Langer, S. Z.: Influence of the frequency of nerve stimulation on the metabolism of 3H-norepinephrine released from the perfused cat spleen: Differences observed during and after the period of stimulation. J. Pharmacol. exp. Ther. 198, 83–101 (1976)

    Google Scholar 

  • Eccleston, D., Ritchie, I. M.: Sulphate ester formation from catecholamine metabolites and pyrogallol in rat brain in vivo. J. Neurochem. 21, 631–646 (1973)

    Google Scholar 

  • Glowinski, J., Axelrod, J.: Effect of drugs on the uptake, release, and metabolism of 3H-norepinephrine in the rat brain. J. Pharmacol. exp. Ther. 149, 43–49 (1965)

    Google Scholar 

  • Glowinski, J., Baldessarini, R. J.: Metabolism of norepinephrine in the central nervous system. Pharmacol. Rev. 18, 1201–1238 (1966)

    Google Scholar 

  • Glowinski, J., Iversen, L. L.: Regional studies of catecholamines in the rat brain.-1. The disposition of [3H]norepinephrine, [3H]dopamine and [3H]dopa in various regions of the brain. J. Neurochem. 13, 655–669 (1966)

    Google Scholar 

  • Glowinski, J., Kopin, I. J., Axelrod, J.: Metabolism of 3H-norepinephrine in the rat brain. J. Neurochem. 12, 25–30 (1965)

    Google Scholar 

  • Graefe, K. H., Stefano, F. J. E., Langer, S. Z.: Preferential metabolism of (−)-3H-noradrenaline through the deaminated glycol in the rat vasdeferens. Biochem. Pharmacol. 22, 1147–1160 (1973)

    Google Scholar 

  • Guldberg, H. C., Marsden, C. A.: Catechol-O-methyltransferase: Pharmacological aspects and physiological role. Pharmacol. Rev. 27, 135–206 (1975)

    Google Scholar 

  • Hendley, E., Taylor, K. M., Snyder, S. M.: 3H-normetanephrine uptake in rat brain slices. Relationship to extraneuronal accumulation of norepinephrine. Europ. J. Pharmacol. 12, 167–179 (1970)

    Google Scholar 

  • Holmes, J. C., Rutledge, C. O.: Effects of the d-and l-isomers of amphetamine on uptake, release and catabolism of norepinephrine, dopamine and 5-hydroxytryptamine in several regions of the brain. Biochem. Pharmacol. 25, 447–451 (1976)

    Google Scholar 

  • Howlett, D. R., Jenner, F. A., Nahorski, S. R.: Urinary 3-methoxy-4-hydroxyphenylglycol production in mice and rats following intraventricular 6-hydroxydopamine. J. Pharm. Pharmacol. 27, 447–449 (1975)

    Google Scholar 

  • Jonason, J.: Metabolism of catecholamines in the central and peripheral nervous system. Acta physiol. scand., Suppl. 320, 1–50 (1969)

    Google Scholar 

  • Korf, J., Aghajanian, G. K., Roth, R. H.: Stimulation and destruction of the locus coeruleus: Opposite effects on 3-methoxy-4-hydroxyphenylglycol sulfate levels in the rat cerebral cortex. Europ. J. Pharmacol. 21, 305–310 (1973)

    Google Scholar 

  • Langer, S. Z.: The metabolism of 3H-noradrenaline released by electrical stimulation from the nictitating membrane of the cat and from the vas deferens of the rat. J. Physiol. (Lond.) 208, 515–546 (1970)

    Google Scholar 

  • Langer, S. Z.: Slective metabolic pathways for noradrenaline in the peripheral and in the central nervous system. Med. Biol. 52, 372–383 (1974)

    Google Scholar 

  • Langer, S. Z., Enero, M. A.: The potentiation of responses to adrenergic nerve stimulation in the presence of cocaine: Its relationship to the metabolic fate of released norepinephrine. J. Pharmacol. exp. Ther. 191, 431–443 (1974)

    Google Scholar 

  • Langer, S. Z., Adler-Graschinsky, E., Almeida, A. P., Diniz, C. R.: Prejunctional effects of a purified toxin fron the scorpion Tityus serrulatus: Release of 3H-noradrenaline and enhancement of transmitter overflow elicited by nerve stimulation. Naunyn-Schmiedeberg's Arch. Pharmacol. 287, 243–259 (1975)

    Google Scholar 

  • Laverty, R., Taylor, K. M.: The fluorimetric assay of catecholamines and related compounds: Improvements and extensions to the hydroxyindole technique. Analyt. Biochem. 22, 269–279 (1968)

    Google Scholar 

  • Leitz, F. H., Stefano, F. J. E.: The effect of tyramine, amphetamine and metaraminol on the metabolic disposition of 3H-norepinephrine released from the adrenergic neuron. J. Pharmacol. exp. Ther. 178, 464–473 (1971)

    Google Scholar 

  • Luchelli-Fortis, M. A., Langer, S. Z.: Reserpine-induced depletion of norepinephrine stores: Is it a reliable criterion for the classification of the mechanism of action of sympathomimetic amines? J. Pharmacol. exp. Ther. 188, 640–653 (1974)

    Google Scholar 

  • Luchelli-Fortis, M. A., Langer, S. Z.: Selective inhibition by hydrocortisone of 3H-normetanephrine formation during 3H-transmitter release elicited by nerve stimulation in the isolated nervemuscle preparation of the cat nictitating membrane. Naunyn-Schmiedeberg's Arch. Pharmacol. 287, 261–275 (1975)

    Google Scholar 

  • Maas, J. W., Landis, D. H.: In vivo studies of the metabolism of norepinephrine in the central nervous system. J. Pharmacol. exp. Ther. 163, 147–162 (1968)

    Google Scholar 

  • Mannarino, E., Kirshner, N., Nashold, B. S., Jr.: The metabolism of (14C)noradrenaline by cat brain in vivo. J. Neurochem. 10, 373–379 (1963)

    Google Scholar 

  • Meek, J. L., Neff, N. H.: Acidic and neutral metabolites of norepinephrine: Their metabolism and transport from brain. J. Pharmacol. exp. Ther. 181, 457–462 (1972)

    Google Scholar 

  • Moguilevsky, J. A., Rubinstein, L.: Glycolytic and oxidative metabolism of hypothalamic areas in prepuberal androgenized rats. Neuroendocrinology 2, 213–221 (1967)

    Google Scholar 

  • Nielsen, M.: Estimation of noradrenaline and its major metabolites synthesized from [3H]tyrosine in the rat brain. J. Neurochem. 27, 493–500 (1976)

    Google Scholar 

  • Noble, E., Wurtman, R. J., Axelrod, J.: A simple and rapid method for injecting 3H-norepinephrine in the lateral ventricle of the rat brain. Life Sci. 6, 281–291 (1967)

    Google Scholar 

  • Rutledge, C. O., Jonason, J.: Metabolic pathways of dopamine and norepinephrine in rabbit brain in vitro. J. Pharmacol. exp. Ther. 157, 493–502 (1967)

    Google Scholar 

  • Schanberg, S. M., Schildkraut, J. J., Breese, G. R., Kopin, I. J.: Metabolism of normetanephrine-H3 in rat brain-identification of conjugated 3-methoxy-4-hydroxyphenylglycol as the major metabolite. Biochem. Pharmacol. 17, 247–254 (1968a)

    Google Scholar 

  • Schanberg, S. M., Breese, G. R., Schildkraut, J. J., Gordon, E. K., Kopin, I. J.: 3-Methoxy-4-hydroxyphenylglycol sulfate in brain and cerebrospinal fluid. Biochem. Pharmacol. 17, 2006–2008 (1968b)

    Google Scholar 

  • Sharman, D. F.: Glycol metabolites of noradrenaline in brain tissue. Brit. J. Pharmacol. 36, 523–534 (1969)

    Google Scholar 

  • Snedecor, G. W., Cochran, W. G.: Statistical methods, 6th ed. Ames: The Iowa State University Press 1967

    Google Scholar 

  • Stefano, F. J. E., Perec, C. J., Tumilasci, O. R.: Changes in neuronal uptake and metabolism of, and sensitivity to, norepinephrine during the degeneration secretion in the rat submaxillary gland. J. Pharmacol. exp. Ther. 191, 403–417 (1974)

    Google Scholar 

  • Stone, E. A.: Accumulation and metabolism of norepinephrine in rat hypothalamus after exhaustive stress. J. Neurochem. 21, 589–601 (1973)

    Google Scholar 

  • Tabakoff, B., Groskoff, W., Anderson, R., Spyridon, B. A. A.: Biogenic aldehyde metabolism relation to pentose shunt activity in brain. Biochem. Pharmacol. 23, 1707–1719 (1974)

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Instituto de Investigaciones Farmacológicas, Consejo Nacional de Investigaciones Cientificas y Técnicas, Iunin 956-5o Piso, (1113), Buenos Aires, Argentina

    M. B. Farah, E. Adler-Graschinsky & S. Z. Langer

Authors
  1. M. B. Farah
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. Adler-Graschinsky
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. Z. Langer
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Farah, M.B., Adler-Graschinsky, E. & Langer, S.Z. Possible physiological significance of the initial step in the catabolism of noradrenaline in the central nervous system of the rat. Naunyn-Schmiedeberg's Arch. Pharmacol. 297, 119–131 (1977). https://doi.org/10.1007/BF00499921

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00499921

Key words

Search

Navigation